Contact this trialFirst, we need to learn more about you.
Progestogen
Progesterone Supplementation for Frozen Embryo Transfer
Recruiting1 awardPhase 2
Montreal, Quebec
This trial is a dose-response study of Endometrin, a progesterone supplement, during in vitro fertilization (IVF). The usual dose of Endometrin is 100 mg two to three times per day. The purpose of this research project is to evaluate the dose response of the Endometrin when determined based on the blood level of progesterone on the day of the FET. The hypothesis is that a woman with low progesterone levels would benefit from a higher dose of Endometrin. PIBF (Progesterone Induced Blocking Factor) levels, a protein found in the blood that could also predict
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.